| 前收市價 | 6.50 |
| 開市 | 無 |
| 買盤 | 6.00 |
| 賣出價 | 9.50 |
| 拍板 | 40.00 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 6.50 - 6.50 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 無 |
ZacksInhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -61.68% and 1,534%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksPharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX
J&J (JNJ) beats estimates for fourth-quarter earnings and sales. Sanofi (SNY) is set to acquire Inhibrx's (INBX) rare disease pipeline candidate, INBRX-101.
ZacksBiotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More
Gilead Sciences (GILD) and Inhibrx (INBX) are in the spotlight on regulatory and pipeline updates.
